Overview

Oral Type I Collagen for Relieving Scleroderma

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Diffuse systemic sclerosis (SSc), or scleroderma, is a connective tissue disease causing damage to skin and other organs. The purpose of this study is to determine if taking oral bovine type I collagen (CI) will improve the condition of SSc patients.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Collaborators:
Baltimore VA Medical Center
Beth Israel Medical Center
Georgetown University
Johns Hopkins University
Medical University of South Carolina
Northwestern University
University of Alabama at Birmingham
University of California, Los Angeles
UTHSC
Wayne State University